FIELD: technological processes.
SUBSTANCE: method of atorvastatin preparation in noncrystalline form includes: a) preparation of solution that contains intermediate compound of the following formula (I) in nonhydroxyl dissolvant: , where A stands for generic protective group or separate protective groups for dihydroxygroup, and B stands for protective group for carboxyl group; b) removal of protection from dihydroxygroup; c) removal of protection from carboxyl group; at that sequence of stages b) and c) may be reverse; d) solution concentration approximately to half or less of initial volume; e) addition of water volume, which is excessive in comparison with volume of concentrated solution; f) addition of dissolvent that poorly mixes or does not mix with water and in which calcium atorvastatin does not dissolve or dissolves poorly, and the volume of this dissolvent is approximately equal to or more than water volume that was added to stage e); g) optional operation of mixing and division into two phases; h) neutralization of water phase; i) conversion of atorvastatin in the form of dihydroxycarboxylic acid into pharmaceutically acceptable form of salt; and j) creation of calcium atorvastatin deposit, which is obtained by conversion to mentioned pharmaceutically acceptable form of salt.
EFFECT: improves stages of calcium atorvastatin preparation out of atorvastatin lactone form.
22 cl, 1 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
FORM VI OF ATORVASTATIN CALCIUM AND ITS HYDRATES | 2002 |
|
RU2294924C2 |
STABLE ATORVASTATIN COMPOSITIONS OBTAINED BY HUMID GRANULATION | 2004 |
|
RU2332211C2 |
CRYSTALLINE FORMS OF [R[(R*,R*)]-2-(4-FLUOROPHENYL)-BETA,DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROL-1-HEPTANOIC ACID | 2004 |
|
RU2315755C2 |
CRYSTALLINE FORMS VI AND VII OF ATORVASTATIN CALCIUM SALT | 2002 |
|
RU2304139C2 |
PHARMACEUTICAL COMPOSITIONS COMPRISING ATORVASTATIN PREPARED WITHOUT GRANULATION | 2004 |
|
RU2314804C2 |
METHOD OF AMORPHOUS CALCIUM ATORVASTATIN OBTAINING | 2005 |
|
RU2330840C1 |
NEW CRYSTALLINE STRUCTURES (POLYMORPHIC MODIFICATIONS) SEMICALCIUM SALT OF ATORVASTATIN AND METHODS OF OBTAINING OF THESE AND OTHER POLYMORPHIC MODIFICATIONS OF SALT OF ATORVASTATIN | 2001 |
|
RU2344127C2 |
METHOD OF PRODUCTION OF MEVALONIC ACID DERIVATIVES INHIBITING HMG-COA REDUCTASE | 2003 |
|
RU2335500C2 |
PHARMACEUTICAL FORMULATION OF ATORVASTATIN | 2004 |
|
RU2325903C2 |
RENNIN INHIBITOR SYNTHESIS WITH USING CYCLOADDITION REACTION | 2006 |
|
RU2423348C2 |
Authors
Dates
2008-05-20—Published
2002-01-22—Filed